LYFAX Mutual Fund

LYFAX Mutual Fund

NAV$16.68
See how much of LYFAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing the top 10 of 62 holdings · as of Jun 30, 2026
Top 10 weight
40.74%
LYFAX top 10 holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
GILD
Gilead SciencesHealth Care · Pharmaceuticals
5.53%		5.5%20,426$2.58MHealth CarePharmaceuticals
2—Nvaesrtex Pharmaceuticals IncHealth Care · Pharmaceuticals
5.33%		10.9%5,002$2.48MHealth CarePharmaceuticals
Share changes, sector and industry · Pro
3—Astrazeneca Plc
4.63%		15.5%11,394$2.16M
4
FXFXX
First Am Treas Obli-X
4.26%		19.8%-$1.99M
5—Roivant Sciences Ltd. Common Shares
3.67%		23.4%48,355$1.71M
6—Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
3.59%		27.0%1,806$1.68M
7
INCY
Incyte Corporation Ltd.
3.51%		30.5%14,451$1.64M
8
NBIX
Neurocrine Biosciences Inc
3.51%		34.0%9,727$1.64M
9
AXSM
Axsome Therapeutics Inc
3.43%		37.5%6,531$1.60M
10
ALLO
Allogene Therapeutics Inc
3.28%		40.7%11,533$1.53M
More holdings · Pro
FundXLS Pro
See the other 52 holdings of LYFAX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime
Themes in the top 10
PharmaceuticalsImmunologyOncologyBiotechnologyLife Sciences ToolsBiotechnology ToolsInterest Rates

LYFAX Mutual Fund Top Holdings

LYFAX holdings top 10 positions. The top 10 holdings account for 40.7% of the fund, led by Gilead Sciences at 5.5%, Nvaesrtex Pharmaceuticals Inc at 5.3%, Astrazeneca Plc at 4.6%.

LYFAX portfolio concentration is moderate, with the top 10 representing 40.7% of total assets. The largest sector exposure is Health Care at 87.7%.

LYFAX sectors provide a detailed breakdown. LYFAX overlap shows how holdings compare to other funds in your portfolio.